De novo progressive multifocal leukoencephalopathy during ocrelizumab treatment in a patient with primary progressive multiple sclerosis.

Ocrevus (ocrelizumab) - Roche

De novo progressive multifocal leukoencephalopathy during ocrelizumab treatment in a patient with primary progressive multiple sclerosis. (PubMed, Neurol Neurochir Pol) - Oct 1, 2026 - No abstract available
Journal • CNS Disorders • Multiple Sclerosis • Rare Diseases

http://www.ncbi.nlm.nih.gov/pubmed/42813531

Alena Martinkova; Edvard Ehler; Leoš Ungermann; Linda Blahová; Martin Vališ; Miroslav Mareš; Simona Halúsková; V?ra K?ivková; Št?pán Frydrych

Oct 1, 2026